Yahoo
HKSE - Delayed Quote HKD

Genertec Universal Medical Group Company Limited (2666.HK)

4.550 +0.030 (+0.66%)
As of 11:22:16 AM GMT+8. Market Open.
Chart Range Bar
Loading chart for 2666.HK
  • Previous Close 4.520
  • Open 4.535
  • Bid 4.545 x --
  • Ask 4.550 x --
  • Day's Range 4.525 - 4.565
  • 52 Week Range 4.320 - 6.670
  • Volume 1,562,500
  • Avg. Volume 5,414,493
  • Market Cap (intraday) 9.165B
  • Beta (5Y Monthly) 0.56
  • PE Ratio (TTM) 3.73
  • EPS (TTM) 1.220
  • Earnings Date Aug 26, 2026
  • Forward Dividend & Yield 0.36 (7.96%)
  • Ex-Dividend Date Jun 26, 2026
  • 1y Target Est 6.77

Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the Mainland China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. Its Healthcare Business segment includes medical and healthcare services; hospital operations; import, export, and trading of medical-related goods; equipment life cycle management; medical digitalization services; and intelligent medical health and elder care. The company also provides medical and professional technology, financing, hospital management, medical consulting, sale of medical related goods, medical, software development, and elderly care services. It serves patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. The company was founded in 1984 and is headquartered in Beijing, China.

www.umcare.cn

23,266

Full Time Employees

December 31

Fiscal Year Ends

Credit Services

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2666.HK
17.41%
HANG SENG INDEX (^HSI)
8.30%

1-Year Return

2666.HK
22.85%
HANG SENG INDEX (^HSI)
10.15%

3-Year Return

2666.HK
39.59%
HANG SENG INDEX (^HSI)
33.06%

5-Year Return

2666.HK
17.10%
HANG SENG INDEX (^HSI)
6.08%

Analyst Insights

View More

Analyst Price Targets

6.77
6.77 Average
4.550 Current
6.77 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.91%

  • Return on Assets (ttm)

    2.70%

  • Return on Equity (ttm)

    9.58%

  • Revenue (ttm)

    14.04B

  • Net Income Avi to Common (ttm)

    2.19B

  • Diluted EPS (ttm)

    1.220

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.48B

  • Total Debt/Equity (mrq)

    192.24%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: